SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

Never Miss a Story

Sign Up For Weekly Top Stories

 

More Industry Headlines

ASTRO 2016: major news from radiation therapy's leading OEMs For improving dose delivery, image guidance is a clear priority

Blue Cross Blue Shield plans ACA exits in two states Will pull out of three markets in Tennessee and Nebraska in 2017

GE will invest $50 million into disruptive health care startups worldwide Launches accelerator five.eight to move the needle on global care

Roughly half of radiotherapy candidates in developing countries lack access: ASTRO It's a 'give a man a fish' problem

NSF awards grant to develop MR-guided robotic biopsies Guidabot designed for real-time imaging of minimally invasive neurological interventions

Boston Scientific to acquire EndoChoice for $210 million Expanding endoscopy presence as pacemakers and implanted defibrillator sales slow

P-Cure showcases seated position imaging solution for proton therapy at ASTRO Could be beneficial for treating upper body indications

SBRT studies show positive results for lung cancer in elderly and prostate cancer New research unveiled at ASTRO

New radiation therapy techniques boost early stage lung cancer survival rates: ASTRO

The ASTRO new product showcase A few products and companies that will be featured at this year's premiere oncology meeting

Dr. Frederic Fahey,
past president of SNMMI

Dose awareness isn't just for CT

by Carol Ko , Staff Writer
Ever since a few high-profile stories put CT dose under the media microscope in 2009, dose scrutiny has spilled over into other modalities — namely molecular imaging. Both governmental agencies like the Food and Drug Administration and the public have consequently expressed more interest in the topic.

"In Boston Children's Hospital, I see parents asking more questions about radiation, its risks, and what it means for their child," Dr. Frederic Fahey, past president-elect of 2012 at the Society of Nuclear Medicine and Molecular Imaging (SNMMI), told DOTmed News. Indeed, concern around radiation dose is commonly cited as one of the barriers to growth in the molecular imaging market.

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material, camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED



Recognizing that dose awareness in molecular imaging is in its relative infancy, Fahey and colleague Dr. Adam Alessio, associate professor at the Imaging Research Laboratory at the University of Washington and Fahey's co-chair for the SNMMI Dose Optimization Working Group, endeavored to organize initiatives during Fahey's presidency that would help move dose awareness forward in the field.

Ultimately, the organization's goal is to help provide practitioners with as much information on dose optimization as it can — a goal that's easier said than done, since there are some logical hurdles to overcome around collecting that information.

For good measure

For example, SNMMI recently worked with the Intersocietal Accreditation Commission (IAC) to help do something that had been only done on a smaller scale before: collect data to see how much levels of radiation dose varied from center to center for the same scan — more specifically, PET and bone scans.

The society gathered and analyzed data submitted to the IAC from sites seeking accreditation — a total of 225 sites that performed MDP bone scans and 95 sites that performed FDG PET scans.

Though on average the median levels of radiation dose fell squarely in line with the levels recommended by the society, there was significant individual variation. On the bone scan side, one patient received 19 millicuries of radiation for another patient's 36. And the radiation levels for PET scans ranged from 3 to 23 millicuries, though the suggested range is 10-20.

Fahey cautions that the data might be biased, since centers that seek accreditation might be more scrupulous in their dose administration than centers that don't, but the study is still the largest review of its sort.

Manual labor

On the manufacturing end, CT dose reduction efforts have been met with measurably significant success, as there's been a big market to satisfy increased demand for lower dose technologies. But whether this momentum will translate over to molecular imaging is questionable.
  Pages: 1 - 2 >>

Related:


Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.
(1)

Mohan Doss

Dose reduction efforts in nuclear medicine are misguided

September 05, 2013 05:02

For diagnostic nuclear medicine, there has not been even a single report that has shown increased cancer risk from radiotracer usage. So, what are the dose reduction efforts going to gain us in terms of reduced cancers? Reduction of excess cancers from zero to zero? How can anyone justify all the dose reduction efforts, with no health benefit to patients?

Though dose reduction has been recommended by many leading scientists, government agencies, and the various professional organizations as being prudent based on the linear no-threshold (LNT) model, there is increasing amount of evidence for the invalidity of the LNT model and for the beneficial effects of low dose radiation including prevention of cancer and neurodegenerative diseases. So, there is no benefit to patients in terms of reduced cancer risks from these dose reduction efforts. Aggressive dose reduction efforts can result in poorer image quality, and this has been described in reports of dose reduction efforts in a recent meeting.

Such dose reduction efforts also tend to validate the current popular superstitious belief about the carcinogenicity of low dose radiation, and discourages and prevents study of its beneficial effects.

In view of the above, I would suggest suspending the current dose monitoring/reduction efforts, and return our focus to improving the image quality and diagnosis.

Mohan Doss
mohan.doss@fccc.edu

Log inor Register

to rate and post a comment

You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2016 DOTmed.com, Inc.
ALL RIGHTS RESERVED